Role and differential expression of calpastatin mRNA and protein in cultured cardiomyocytes exposed to hypoxic stress

Molecular and Cellular Biochemistry

Volumn 265, Issue 1-2, 2004, Pages 63-70

  Lin, Huey ^a   Risbood, Milish P ^a   Jain, Atul ^a   Vacanti, Victor ^a   Lee, Techung ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Calpain; Calpastatin; Cardiomyocytes; Hypoxia; Troponin I

Indexed keywords

ADENOVIRUS VECTOR; CALPASTATIN; TROPONIN I; VASCULOTROPIN; CALCIUM BINDING PROTEIN; CALPAIN; COMPLEMENTARY DNA; MESSENGER RNA;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL FUNCTION; CONTROLLED STUDY; FIBROBLAST; GENETIC TRANSCRIPTION; HEART MUSCLE CELL; HYPOXIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION; ADENOVIRUS; ALTERNATIVE RNA SPLICING; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL HYPOXIA; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NEWBORN; PATHOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; SPRAGUE DAWLEY RAT;

ADENOVIRIDAE; ANIMALIA;

ADENOVIRIDAE; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; ANIMALS, NEWBORN; CALCIUM-BINDING PROTEINS; CALPAIN; CELL HYPOXIA; CELLS, CULTURED; DNA, COMPLEMENTARY; FIBROBLASTS; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MYOCYTES, CARDIAC; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION, GENETIC; TROPONIN I;

EID: 16644379759     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000044316.04876.6f     Document Type: Article

References (50)

1. Nayler WG: The role of calcium in the ischemic myocardium. Am J Pathol 102:262-270, 1981
2. Ver Donck L, Borgers M, Verdonck F: Inhibition of sodium and calcium overload pathology in the myocardium: A new cytoprotective principle. Cardiovasc Res 27: 349-357, 1993
3. Atsma DE, Bastiaanse EM, Jerzewski A, Van der Valk LJ, Van der Laarse A: Role of calcium-activated neutral protease (calpain) in cell death in cultured neonatal rat cardiomyocytes during metabolic inhibition. Circ Res 76: 1071-1078, 1995
4. Kositprapa C, Zhang B, Berger S, Canty JMJ, Lee TC: Calpain-mediated proteolytic cleavage of troponin I induced by hypoxia or metabolic inhibition in cultured neonatal cardiomyocytes. Mol Cell Biochem 214: 47-55, 2000
5. Ganote C, Armstrong S: Ischaemia and the myocyte cytoskeleton: Review and speculation. Cardiovasc Res 27: 1387-1403, 1993
6. McDonough JL, Arrell DK, Van Eyk JE: Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res 84: 9-20, 1999
7. Blomgren K, McRae A, Bona E, Saido TC, Karlsson J-O, Hagberg H: Degradation of fodrin and MAP2 after neonatal cerebral hypoxic-ischemia. Brain Res 684: 136-142, 1995
8. Blomgren K, Hallin U, Andersson AL, Puke-Sundvall M, Bahr BA, McRae A, Saido TC, Kawashima S, Hagberg H: Calpastatin is upregulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia. J Biol Chem 274: 14046-14052, 1999
9. Wang KKW, Yuen P-W: Calpain inhibition: An overview of its therapeutic potential. Trends Pharmacol Sci 15: 412-419, 1994
10. Squier MK, Miller AC, Malkinson AM, Cohen JJ: Calpain activation in apoptosis. J Cell Physiol 159: 229-237, 1994
11. Badalamente MA, Stracher A: Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition. Muscle Nerve 23: 106-111, 2000
12. Bartus RT, Elliott PJ, Hayward NJ, Dean RL, Harbeson S, Straub JA, Li Z, Powers JC: Calpain as a novel target for treating acute neurodegenerative disorders. Neurol Res 17:249-258, 1995
13. Schoenwaelder SM, Burridge K: Evidence for a calpeptin-sensitive protein-tyrosine phosphatase upstream of the small GTPase Rho. J Biol Chem 274: 14359-14367, 1999
14. Melloni E, Salamino F, Sparatore B: The calpain-calpastatin system in mammalian cells: Properties and possible functions. Biochimie 74: 217-223, 1992
15. Goll DE, Thompson VF, Li H, Wei W, Cong J: The calpain system. Physiol Rev 83: 731-801, 2003
16. Nishimura T, Goll DE: Binding of calpain fragments to calpastatin. J Biol Chem 266: 11842-11850, 1991
17. Nakamura M, Inomata M, Imajoh S, Suzuki K, Kawashima S: Fragmentation of an endogenous inhibitor upon complex formation with high- and low-calcium-requiring forms of calcium-activated neutral proteases. Biochemistry 28: 449-455, 1989
18. Takano E, Ueda M, Tsunekawa S, Murakami T, Maki M, Hatanaka M, Murachi T: Molecular diversity of erythrocyte calpastatin. Biomed Biochim Acta 50: 517-521, 1991
19. Takano E, Maki M, Mori H, Hatanaka M, Marti T, Titani K, Kannagi R, Ooi T, Murachi T: Pig heart calpastatin: Identification of repetitive domain structures and anomalous behavior in polyacrylamide gel electrophoresis. Biochemistry 27: 1964, 1988
20. Ishida S, Emori Y, Suzuki K: Rat calpastatin has diverged primary sequence from other mammalian calpastatins but retains functionally important sequences. Biochim Biophys Acta 1088: 436-438, 1991
21. Lee WJ, Hatanaka M, Maki M: Multiple forms of rat calpastatin cDNA in the coding region of functionally unknown amino-terminal domain. Biochim Biophys Acta 1129: 251-253, 1992
22. Takano J, Watanabe M, Hitomi K, Maki M: Four types of calpastatin isoforms with distinct amino-terminal sequences are specified by alternative first exons and differentially expressed in mouse tissues. J Biochem 128: 83-92, 2000
23. De Tullio R, Sparatore B, Salamino F, Melloni E, Pontremoli S: Rat brain contains multiple mRNAs for calpastatin. FEBS Lett 422: 113-117, 1998
24. Adachi Y, Ishida-Takahashi A, Takahashi C, Takano E, Murachi T, Hatanaka M: Phosphorylation and subcellular distribution of calpastatin in human hematopoietic system cells. J Biol Chem 266: 3968-3972, 1991
25. Cong M, Thompson VF, Goll DE, Antin PB: The bovine calpastatin gene promoter and a new N-terminal region of the protein are targets for cAMP-dependent protein kinase activity. J Biol Chem 273: 660-666, 1998
26. Chen SJ, Bradley ME, Lee TC: Chemical hypoxia triggers apoptosis of cultured neonatal rat cardiac myocytes: Modulation by calcium-regulated proteases and protein kinases. Mol Cell Biochem 178: 141-149, 1998
27. Walowitz JL, Bradley ME, Chen SJ, Lee TC: Proteolytic regulation of the zinc finger transcription factor YY1, a repressor of muscle-estricted gene expression. J Biol Chem 273: 6656-6661, 1998
28. Sabath DE, Broome HE, Prystowsky MB: Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene 91: 185-191, 1990
29. Guillemin K, Krasnow MA: The hypoxic response: Huffing and HIFing. Cell 89: 9-12, 1997
30. Ferrara N: Vascular endothelial growth factor. Eur J Cancer 32A: 2413-2422, 1996
31. Asada K, Ishino Y, Shimada M, Shimojo T, Endo M, Kimizuka F, Kato I, Maki M, Hatanaka M, Murachi T: A cloning of human calpastatin: structural comparison between human, pig, and rabbit calpastatins. J Enzyme Inhibition 3: 49-56, 1989
32. Borger DR, Essig DA: Induction of HSP 32 gene in hypoxic cardiomyocytes is attenuated by treatment with N-acetyl-L-cysteine. Am J Physiol 274: H965-H973, 1998
33. Lee PJ, Jiang B-H, Chin BY, Iyer NV, Alam J, Semenza GL, Choi AMK: Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 272: 5375-5381, 1997
34. Wang GL, Jiang B-H, Rue EA, Semenza GL: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular oxygen tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995
35. De Tullio R, Averna M, Salamino F, Pontremoli S, Melloni E: Differential degradation of calpastatin by mu- and m- calpain in calcium-enriched human neuroblastoma LAN-5 cells. FEBS Lett 475: 17-21, 2000
36. Barnoy S, Supino-Rosin L, Kosower NS: Regulation of calpain and calpastatin in differentiating myoblasts: mRNA levels, protein synthesis and stability. Biochem J 351: 413-420, 2000
37. Salamino F, De Tullio R, Michetti M, Mengotti P, Melloni E, Pontremoli S: Modulation of calpastatin specificity in rat tissues by reversible phosphorylation and dephosphorylation. Biochem Biophys Res Commun 199: 1326-1332, 1994
38. Averna M, De Tullio R, Passalacqua M, Salamino F, Pontremoli S, Melloni E: Changes in intracellular calpastatin localization are mediated by reversible phosphorylation. Biochem J 354: 25-30, 2001
39. Doumit ME, Koohmaraie M: Immunoblot analysis of calpastatin degradation: evidence for cleavage by calpain in postmortem muscle. J Anim Sci 77: 1467-1473, 1999
40. Wang KKW, Posmantur R, Nadimpalli R: Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch Biochem Biophys 356: 187-196, 1998
41. Mellgren RL, Mericle MT, Lane RD: Proteolysis of the calcium-dependent protease inhibitor by myocardial calcium-dependent protease. Arch Biochem Biophys 246: 233-239, 1986
42. Nagao S, Saido TC, Akita Y, Tsuchiya T, Suzuki K, Kawashima S: Calpain-calpastatin interactions in epidermoid carcinoma KB cells. J Biochem 115: 1178-1184, 1994
43. Hall E, Lockley AK, Parr T, Bardsley RG: Interaction of calpastatin isoforms with L-type calcium channels. Biochem Soc Trans 26: S307, 1998
44. Murphy AM, Kogler H, Georgakopoulos D, McDonough JL, Kass DA, Van Eyk JE, Marban E: Transgenic mouse model of stunned myocardium. Science 287: 488-491, 2000
45. Huang X, Pi Y, Lee KJ, Henkel AS, Gregg RG, Powers PA, Walker, JW: Cardiac troponin I gene knockout. A mouse model of myocardial troponin I deficiency. Circ Res 84: 1-8, 1999
46. Tidball JG, Spencer MJ: Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse. J Physiol 545: 819-828, 2002
47. Perez-Pinzon MA, Mumford PL, Carranza V, Sick TJ: Calcium influx from the extracellular space promotes NADH hyperoxidation and electrical dysfunction after anoxia in hippocampal slices. J Cereb Blood Flow Metab 18: 215-221, 1998
48. Schafer M, Bahde D, Bosche B, Ladilov Y, Schafer C, Piper HM, Noll T: Modulation of early [Ca2+]i rise in metabolically inhibited endothelial cells by xestospongin C. Am J Physiol Heart Circ Physiol 280: H1002-H1010, 2001
49. Spencer MJ, Mellgren RL: Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology. Hum Mol Genet 11: 2645-2655, 2002
50. Costelli P, Tullio RD, Baccino FM, Melloni E: Activation of calcium-dependent proteolysis in skeletal muscle and heart in cancer cachexia. Br J Cancer 84: 946-950, 2001